COVAXIN phase 3 full trial data will be made public in July:...

New Delhi [India], June 9 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its...

China's Sinopharm publishes awaited COVID vaccine trial data;...

Beijing [China], May 27 (ANI): The Chinese drug maker Sinopharm has finally published the interim results of a phase...

Regeneron antibody cocktail 'helps prevent' symptomatic...

New York [US], April 13 (ANI): New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail...

Russia's Sputnik V COVID-19 vaccine 91.6 per cent effective:...

Moscow [Russia], February 2 (ANI): Russian's Sputnik V is 91.6 per cent effective at protecting people from...

COVID-19 vaccine of US company Novavax shows 89.3 pc efficacy...

Maryland [US], January 29 (ANI/Sputnik): The coronavirus vaccine developed by the US company Novavax has...

Russian COVID-19 vaccine in phase 3 trial, to cost below USD...

New Delhi [India], January 21 (ANI): The Russian COVID-19 vaccine 'Sputnik V' will cost less than USD 10 (about Rs...

Indians are not guinea pigs, you can't use Covaxin rollout as...

New Delhi [India], January 14 (ANI): Congress leader Manish Tewari on Wednesday said that emergency use...

Approval to Covaxin premature, could be dangerous: Tharoor

New Delhi [India], January 3 (ANI): Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval...

US launches Phase 3 trial of 2 new antibody treatments for...

Washington [US], December 18 (ANI): The United States, on Thursday, announced phase 3 clinical trials of two...

Sputnik V vaccine efficacy confirmed at '91.4 per cent'...

Moscow [Russia], December 14 (ANI): The efficacy of the Sputnik V COVID-19 vaccine has been confirmed to be 91.4...

'Got only first dose of coronavirus vaccine, antibodies...

New Delhi [India], December 6 (ANI): Haryana Home Minister Anil Vij who tested positive for Covid-19 on December 5...

Sola Civil Hospital in Ahmedabad begins Phase-3 trial of Covaxin

Ahmedabad (Gujarat) [India], November 27 (ANI): The Phase-3 trial of COVID-19 vaccine candidate Covaxin begun with...